John Lien, MD
Cardiovascular Disease (Cardiology) · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 36
- 10 carriers
- Office
- 1
Offices
1 location
Plans that list them
36 plans · 10 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Lien’s office at (408) 251-7900 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
36 of 36 plans
| Advantage Care (HMO) | Align Senior Care | Listed | Oct 1, 2026 |
| Premier Care (HMO I-SNP) | Align Senior Care | Listed | Oct 1, 2026 |
| Senior Care (HMO I-SNP) | Align Senior Care | Listed | Oct 1, 2026 |
| Alignment Health Advantage PPO (PPO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Prime (HMO-POS) | Anthem Blue Cross Partnership Plan | Listed | Oct 3, 2026 |
| Astiva Health C-SNP WOW - NorCal (HMO C-SNP) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Premier Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Savings Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Blue Shield Inspire (HMO) | Blue Shield of California | Listed | Aug 26, 2026 |
| Central Health Classic Care Plan III (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Dual Access Plan (HMO D-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Embrace Care Plan (HMO C-SNP) | Central Health Medicare Plan | Listed, may be out of date | Sep 15, 2025 |
| Central Health Embrace Choice Plan (HMO C-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Valor Care Plan (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
Original Medicare doctor bills
$590,965
Medicare paid this office $590,965 for 719 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress with concurrent ct scan | 62 | $123,613 | $1,994 |
| Return visit (30+ min) | 654 | $119,319 | $109 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 115 | $95,439 | $408 |
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress | 54 | $84,712 | $1,569 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 238 | $48,829 | $202 |
See all 20 services
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress with concurrent ct scan | 62 | $123,613 | $1,994 |
| Return visit (30+ min) | 654 | $119,319 | $109 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 115 | $95,439 | $408 |
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress | 54 | $84,712 | $1,569 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 238 | $48,829 | $202 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 39 | $18,246 | $468 |
| New patient visit (45+ min) | 119 | $15,346 | $129 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 39 | $13,759 | $179 |
| Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | 14 | $10,976 | $784 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 153 | $10,845 | $70 |
| Nuclear medicine study of heart muscle blood flow by pet | 62 | $8,814 | $140 |
| Long return visit (40+ min) | 28 | $4,923 | $164 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 261 | $3,694 | $13 |
| Programming of dual lead pacemaker system | 27 | $3,687 | $70 |
| Injection, regadenoson, 0.1 mg | 146 | $3,270 | None |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 16 | $2,788 | $155 |
| Short return visit (20+ min) | 12 | $1,059 | $88 |
| Injection, aminophyllin, up to 250 mg | 52 | $323 | None |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 14 | $318 | $23 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 17 | $178 | $10 |
Procedures Medicare counted
| Coronary angioplasty and stenting | 1-10 | None |
Who their Medicare patients are
719 Original Medicare patients in 2024. Average age 78 · Under 65 2% · 85 and older 23% · Women 59% · Also on Medicaid 87% · Health risk score 1.57. At or below the middle of the specialty; the typical cardiology clinician is at 1.71.
Conditions among them: High blood pressure 75% · Diabetes 60% · Chronic kidney disease 39% · Heart failure 37% · Coronary heart disease 36% · Atrial fibrillation 22% · COPD 14% · Dementia 10% · Stroke 10% · Cancer 9% · Depression 7%.
The office billed $1,255,428, Medicare allowed $769,540 and paid $590,965; for 3,279 services of 30 kinds; $3,593 of it was for drugs given in the office and $587,372 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 719 | 3,279 | 78 | 1.57 | $1,255,428 | $590,965 |
| 2023 | 767 | 7,072 | 79 | 1.61 | $1,570,721 | $737,549 |
| 2022 | 824 | 12,556 | 78 | 1.52 | $1,476,256 | $737,365 |
| 2021 | 780 | 11,840 | 78 | 1.56 | $1,258,964 | $554,596 |
| 2020 | 823 | 11,343 | 78 | 1.62 | $1,194,065 | $558,271 |
| 2019 | 1,031 | 22,051 | 77 | 1.51 | $1,843,669 | $788,106 |
| 2018 | 1,075 | 26,828 | 77 | 1.56 | $2,101,783 | $928,373 |
| 2017 | 1,117 | 26,709 | 76 | 1.49 | $2,026,545 | $794,440 |
| 2016 | 1,143 | 26,270 | 76 | 1.57 | $1,872,857 | $688,908 |
| 2015 | 1,155 | 32,449 | 76 | 1.52 | $2,127,731 | $818,710 |
| 2014 | 1,344 | 36,128 | 75 | 1.38 | $2,693,883 | $1,120,930 |
| 2013 | 1,343 | 7,152 | 75 | 1.41 | $2,368,560 | $920,486 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 25 services
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress with concurrent ct scan | 71 | $143,184 | $2,017 |
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress | 90 | $142,798 | $1,587 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 161 | $132,658 | $412 |
| Return visit (30+ min) | 699 | $131,978 | $112 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 247 | $50,773 | $204 |
| New patient visit (45+ min) | 136 | $19,448 | $143 |
| Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | 18 | $15,838 | $792 |
| Injection, regadenoson, 0.1 mg | 100 | $15,739 | None |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 192 | $13,706 | $71 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 26 | $12,380 | $476 |
| Nuclear medicine study of heart muscle blood flow by pet | 71 | $10,091 | $142 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 26 | $8,859 | $170 |
| Long return visit (40+ min) | 35 | $6,539 | $159 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 21 | $5,232 | $249 |
| Programming of dual lead pacemaker system | 37 | $4,827 | $74 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 306 | $4,798 | $13 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 25 | $4,104 | $158 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 16 | $2,664 | $72 |
| New patient visit (60+ min) | 12 | $2,239 | $187 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 23 | $1,676 | $67 |
| Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) | 86 | $1,404 | None |
| Short return visit (20+ min) | 21 | $1,222 | $58 |
| Injection, aminophyllin, up to 250 mg | 70 | $520 | None |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 18 | $466 | $23 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 30 | $325 | $11 |
2022: 21 services
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress | 169 | $268,313 | $1,588 |
| Return visit (30+ min) | 668 | $133,394 | $107 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 169 | $128,590 | $380 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 287 | $58,850 | $204 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 48 | $23,436 | $488 |
| Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | 28 | $22,795 | $786 |
| New patient visit (45+ min) | 144 | $18,607 | $129 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 232 | $16,107 | $69 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 47 | $11,714 | $125 |
| Short return visit (20+ min) | 197 | $11,205 | $52 |
| Long return visit (40+ min) | 43 | $7,603 | $149 |
| Programming of dual lead pacemaker system | 41 | $5,566 | $70 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 369 | $5,347 | $13 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 19 | $4,801 | $253 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 21 | $4,477 | $179 |
| Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) | 214 | $3,347 | None |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 33 | $2,637 | $73 |
| New patient visit (60+ min) | 13 | $2,555 | $197 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 12 | $1,674 | $64 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 28 | $614 | $21 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 31 | $341 | $11 |
2021: 21 services
| Return visit (30+ min) | 679 | $142,865 | $110 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 159 | $84,182 | $529 |
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress | 40 | $65,520 | $1,638 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 277 | $60,537 | $214 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 158 | $36,711 | $116 |
| Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | 40 | $32,712 | $798 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 40 | $31,159 | $389 |
| New patient visit (45+ min) | 128 | $17,779 | $139 |
| Long return visit (40+ min) | 86 | $17,711 | $164 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 209 | $13,705 | $65 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 35 | $7,057 | $186 |
| Short return visit (20+ min) | 111 | $6,940 | $57 |
| Programming of dual lead pacemaker system | 38 | $5,352 | $70 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 301 | $4,722 | $14 |
| Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | 13 | $4,659 | $333 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 59 | $4,598 | $74 |
| New patient visit (60+ min) | 21 | $4,112 | $196 |
| Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) | 194 | $3,854 | None |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 22 | $3,198 | $67 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 40 | $914 | $22 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 24 | $299 | $12 |
2020: 23 services
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress | 111 | $186,827 | $1,683 |
| Return visit (30+ min) | 593 | $97,902 | $92 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 111 | $86,508 | $390 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 238 | $51,889 | $214 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 40 | $20,501 | $513 |
| Short return visit (20+ min) | 370 | $18,827 | $40 |
| Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | 15 | $11,920 | $795 |
| New patient visit (45+ min) | 89 | $11,759 | $132 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 155 | $11,052 | $70 |
| Long return visit (40+ min) | 62 | $10,501 | $133 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 31 | $8,119 | $68 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 40 | $7,844 | $98 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 36 | $7,706 | $188 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 355 | $6,898 | $17 |
| Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) | 149 | $3,827 | None |
| New patient visit (60+ min) | 20 | $3,543 | $177 |
| Programming of dual lead pacemaker system | 31 | $3,407 | $66 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 25 | $2,275 | $88 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 15 | $373 | $25 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 15 | $313 | $21 |
| External ekg recording for more than 48 hours up to 21 days | 11 | $225 | $20 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 15 | $210 | $14 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 11 | $197 | $18 |
2019: 26 services
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress | 129 | $202,092 | $1,567 |
| Return visit (30+ min) | 887 | $181,921 | $92 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 129 | $98,916 | $383 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 371 | $79,468 | $210 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 139 | $71,340 | $510 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 139 | $27,217 | $97 |
| New patient visit (45+ min) | 159 | $20,161 | $127 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 280 | $18,818 | $67 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 79 | $15,294 | $184 |
| Short return visit (20+ min) | 180 | $12,765 | $64 |
| Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) | 266 | $9,852 | None |
| Long return visit (40+ min) | 57 | $8,236 | $123 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 55 | $7,423 | $66 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 13 | $6,670 | $513 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 349 | $5,980 | $16 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 22 | $5,728 | $260 |
| Programming of dual lead pacemaker system | 38 | $4,024 | $54 |
| Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | 12 | $3,943 | $329 |
| New patient visit (60+ min) | 16 | $2,829 | $177 |
| Insertion of tube in left heart chambers for diagnosis with review by radiologist | 12 | $1,263 | $105 |
| New patient visit (30+ min) | 11 | $922 | $84 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 34 | $697 | $20 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 34 | $468 | $14 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 33 | $367 | $11 |
| External ekg recording for more than 48 hours up to 21 days | 11 | $310 | $28 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 11 | $271 | $25 |
2018: 23 services
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress | 228 | $350,822 | $1,539 |
| Return visit (30+ min) | 878 | $155,068 | $85 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 228 | $143,782 | $315 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 364 | $74,939 | $204 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 92 | $45,502 | $495 |
| New patient visit (45+ min) | 173 | $21,778 | $126 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 328 | $21,667 | $66 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 92 | $17,030 | $93 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 77 | $15,043 | $175 |
| Short return visit (20+ min) | 250 | $14,564 | $54 |
| Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) | 318 | $12,930 | None |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 41 | $9,794 | $239 |
| Long return visit (40+ min) | 51 | $6,974 | $122 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 382 | $6,556 | $15 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 41 | $5,707 | $63 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 11 | $5,149 | $468 |
| Programming of dual lead pacemaker system | 47 | $4,128 | $51 |
| Ultrasound of both sides of head and neck blood flow | 18 | $3,539 | $197 |
| New patient visit (60+ min) | 19 | $3,204 | $169 |
| New patient visit (30+ min) | 14 | $1,306 | $93 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 14 | $970 | $65 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 32 | $623 | $19 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 32 | $418 | $13 |
2017: 24 services
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress | 168 | $245,930 | $1,447 |
| Return visit (30+ min) | 791 | $138,510 | $83 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 182 | $85,375 | $467 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 168 | $73,271 | $216 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 333 | $71,716 | $212 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 182 | $32,621 | $89 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 356 | $23,474 | $65 |
| New patient visit (45+ min) | 168 | $21,501 | $128 |
| Short return visit (20+ min) | 345 | $20,737 | $50 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 74 | $14,186 | $169 |
| Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) | 327 | $9,984 | None |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 16 | $8,374 | $465 |
| Ultrasound of both sides of head and neck blood flow | 41 | $7,908 | $193 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 31 | $7,426 | $240 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 44 | $5,794 | $60 |
| Complete ultrasound study of arm and leg arteries | 38 | $5,064 | $133 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 314 | $4,623 | $14 |
| Programming of dual lead pacemaker system | 41 | $3,701 | $46 |
| Long return visit (40+ min) | 24 | $3,076 | $123 |
| New patient visit (30+ min) | 32 | $1,962 | $61 |
| Insertion of tube in left heart chambers for diagnosis with review by radiologist | 16 | $1,543 | $96 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 19 | $1,023 | $54 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 35 | $654 | $19 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 35 | $439 | $13 |
2016: 23 services
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress | 90 | $128,925 | $1,432 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 237 | $116,782 | $483 |
| Return visit (30+ min) | 632 | $95,556 | $83 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 312 | $67,248 | $213 |
| Short return visit (20+ min) | 603 | $49,116 | $57 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 237 | $46,181 | $95 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 90 | $39,956 | $222 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 161 | $30,197 | $173 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 328 | $21,593 | $65 |
| New patient visit (45+ min) | 163 | $19,289 | $118 |
| Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) | 301 | $12,673 | None |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 97 | $11,362 | $62 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 14 | $6,952 | $497 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 26 | $6,629 | $255 |
| Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | 17 | $5,497 | $323 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 317 | $4,865 | $15 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 82 | $4,623 | $55 |
| Ultrasound of both sides of head and neck blood flow | 29 | $4,376 | $151 |
| New patient visit (30+ min) | 50 | $4,032 | $81 |
| Programming of dual lead pacemaker system | 37 | $3,322 | $51 |
| Insertion of tube in left heart chambers for diagnosis with review by radiologist | 18 | $1,781 | $99 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 83 | $1,596 | $19 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 83 | $1,041 | $13 |
2015: 22 services
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 344 | $168,671 | $490 |
| Return visit (30+ min) | 690 | $115,043 | $92 |
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress | 79 | $113,645 | $1,439 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 409 | $92,313 | $223 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 344 | $91,074 | $132 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 79 | $35,327 | $224 |
| Short return visit (20+ min) | 497 | $33,552 | $55 |
| New patient visit (45+ min) | 246 | $32,661 | $133 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 429 | $27,977 | $65 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 119 | $24,704 | $176 |
| Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) | 409 | $18,873 | None |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 48 | $12,438 | $259 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 69 | $9,792 | $63 |
| Long return visit (40+ min) | 62 | $8,087 | $119 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 397 | $6,495 | $16 |
| Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | 14 | $4,556 | $325 |
| New patient visit (60+ min) | 23 | $4,144 | $180 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 47 | $2,738 | $56 |
| Programming of dual lead pacemaker system | 30 | $2,726 | $53 |
| New patient visit (30+ min) | 25 | $2,040 | $82 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 38 | $744 | $20 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 38 | $485 | $13 |
2014: 25 services
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 463 | $229,855 | $493 |
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress | 111 | $162,789 | $1,453 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 565 | $129,429 | $226 |
| Return visit (30+ min) | 731 | $124,903 | $96 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 462 | $122,338 | $132 |
| Injection, adenosine for diagnostic use, 1 mg (not to be used to report any adenosine phosphate compounds, instead use a9270) | 547 | $63,392 | None |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 111 | $51,218 | $229 |
| Short return visit (20+ min) | 615 | $49,497 | $61 |
| New patient visit (45+ min) | 290 | $40,965 | $141 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 581 | $38,595 | $65 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 151 | $30,938 | $180 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 59 | $16,187 | $270 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 535 | $8,970 | $16 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 55 | $8,519 | $64 |
| Removal of plaque and blood clot, insertion of stent and/or balloon dilation of single vessel | 12 | $7,531 | $579 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 13 | $7,234 | $517 |
| Long return visit (40+ min) | 53 | $7,171 | $130 |
| Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | 13 | $4,405 | $339 |
| New patient visit (30+ min) | 47 | $3,798 | $81 |
| New patient visit (60+ min) | 15 | $2,813 | $188 |
| Programming of dual lead pacemaker system | 28 | $2,801 | $55 |
| Insertion of tube in left heart chambers for diagnosis with review by radiologist | 22 | $2,744 | $119 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 38 | $2,182 | $57 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 21 | $417 | $20 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 21 | $273 | $13 |
2013: 27 services
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 505 | $262,542 | $513 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 505 | $135,602 | $132 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 515 | $97,700 | $186 |
| Short return visit (20+ min) | 866 | $86,098 | $61 |
| Injection, adenosine for diagnostic use, 30 mg (not to be used to report any adenosine phosphate compounds; instead use a9270) | 428 | $74,653 | None |
| Return visit (30+ min) | 470 | $60,370 | $89 |
| New patient visit (45+ min) | 313 | $43,711 | $140 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 529 | $36,041 | $67 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 151 | $29,719 | $175 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 57 | $15,000 | $263 |
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress | 11 | $13,027 | $1,184 |
| Removal of plaque and blood clot, insertion of stent and/or balloon dilation of single vessel | 17 | $9,606 | $565 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 70 | $9,579 | $63 |
| New patient visit (30+ min) | 91 | $7,909 | $87 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 441 | $7,841 | $17 |
| Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | 18 | $5,939 | $330 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 11 | $5,034 | $229 |
| Programming of dual lead pacemaker system | 29 | $2,508 | $51 |
| Insertion of tube in left heart chambers for diagnosis with review by radiologist | 19 | $2,251 | $118 |
| New patient visit (60+ min) | 12 | $2,230 | $186 |
| Long return visit (40+ min) | 17 | $2,136 | $126 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 28 | $2,093 | $75 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 36 | $1,992 | $55 |
| Short return visit | 25 | $1,899 | $37 |
| Hospital discharge day management, 30 minutes or less | 13 | $834 | $64 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 28 | $559 | $19 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 28 | $371 | $13 |
Medicaid work
$10,716 in 2024
Medicaid paid $10,716 for 2,150 billed services this clinician did in 2024, up to 69 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 173 | $5,783 |
| Return visit (30+ min) | 729 | $3,750 |
| Myocardial perfusion imaging, tomographic (SPECT) (including attenuation correction, qualitative or quantitative wall motion, ejection fraction by first pass or gated technique, additional quantification, when performed); multiple studies, at rest and/or stress (exercise or pharmacologic) and/or redistribution and/or rest reinjection | 12 | $359 |
| New patient visit (45+ min) | 12 | $332 |
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 70 | $257 |
| CARDIOVASCULAR STRESS TEST | 90 | $236 |
| Advance Care Planning discussed and documented advance care plan or surrogate decision maker documented in the medical record (DEM) (GER, Pall Cr) | 12 | $0 |
| Bmi is documented within normal parameters and no follow-up plan is required | 63 | $0 |
| Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | 138 | $0 |
| Patient not eligible due to active diagnosis of hypertension | 386 | $0 |
| Patient screened for tobacco use and identified as a tobacco non-user | 465 | $0 |
| 2024 | 2,150 | 11 | 69 | $10,716 |
| 2023 | 5,549 | 19 | 137 | $24,755 |
| 2022 | 3,448 | 9 | 125 | $17,979 |
| 2021 | 3,831 | 12 | 144 | $14,984 |
| 2020 | 2,964 | 8 | 126 | $12,985 |
| 2019 | 2,807 | 16 | 105 | $19,759 |
| 2018 | 3,068 | 18 | 91 | $21,213 |
See the largest Medicaid services in earlier years
2023
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 428 | $10,960 |
| Return visit (30+ min) | 1,424 | $10,451 |
| New patient visit (45+ min) | 311 | $1,591 |
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 590 | $984 |
| CARDIOVASCULAR STRESS TEST | 305 | $648 |
| Myocardial perfusion imaging, tomographic (SPECT) (including attenuation correction, qualitative or quantitative wall motion, ejection fraction by first pass or gated technique, additional quantification, when performed); multiple studies, at rest and/or stress (exercise or pharmacologic) and/or redistribution and/or rest reinjection | 37 | $121 |
| TOBACCO NON-USER | 346 | $0 |
| Advance Care Planning discussed and documented advance care plan or surrogate decision maker documented in the medical record (DEM) (GER, Pall Cr) | 77 | $0 |
| Advance Care Planning discussed and documented in the medical record, patient did not wish or was not able to name a surrogate decision maker or provide an advance care plan (DEM) (GER, Pall Cr) | 33 | $0 |
| Tc99m sestamibi | 30 | $0 |
| Bmi is documented below normal parameters and a follow-up plan is documented | 12 | $0 |
| Bmi is documented within normal parameters and no follow-up plan is required | 369 | $0 |
2022
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 414 | $10,547 |
| Return visit (30+ min) | 1,263 | $4,043 |
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 581 | $1,138 |
| New patient visit (45+ min) | 260 | $1,127 |
| Short return visit (20+ min) | 243 | $671 |
| CARDIOVASCULAR STRESS TEST | 284 | $454 |
| TOBACCO NON-USER | 265 | $0 |
| Patient not eligible due to active diagnosis of hypertension | 119 | $0 |
| Pt scrn tbco and id as user | 19 | $0 |
2021
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 435 | $8,387 |
| Return visit (30+ min) | 1,368 | $4,146 |
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 534 | $870 |
| New patient visit (45+ min) | 274 | $842 |
| CARDIOVASCULAR STRESS TEST | 310 | $350 |
| Short return visit (20+ min) | 74 | $319 |
| Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) | 45 | $64 |
| Myocardial perfusion imaging, tomographic (SPECT) (including attenuation correction, qualitative or quantitative wall motion, ejection fraction by first pass or gated technique, additional quantification, when performed); multiple studies, at rest and/or stress (exercise or pharmacologic) and/or redistribution and/or rest reinjection | 111 | $4 |
| Tc99m sestamibi | 42 | $2 |
| TOBACCO NON-USER | 264 | $0 |
| Patient not eligible due to active diagnosis of hypertension | 362 | $0 |
| Pt scrn tbco and id as user | 12 | $0 |
2020
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 289 | $6,711 |
| Return visit (30+ min) | 933 | $3,559 |
| Short return visit (20+ min) | 440 | $1,654 |
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 502 | $750 |
| New patient visit (45+ min) | 122 | $248 |
| CARDIOVASCULAR STRESS TEST | 140 | $63 |
| Aspirin or clopidogrel prescribed or currently being taken (CAD) | 28 | $0 |
| Patient not eligible due to active diagnosis of hypertension | 510 | $0 |
2019
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 445 | $10,505 |
| Return visit (30+ min) | 917 | $5,336 |
| New patient visit (45+ min) | 133 | $1,230 |
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 380 | $1,177 |
| CARDIOVASCULAR STRESS TEST | 295 | $1,028 |
| Short return visit (20+ min) | 80 | $253 |
| Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) | 30 | $211 |
| Tc99m sestamibi | 81 | $20 |
| TOBACCO NON-USER | 32 | $0 |
| Myocardial perfusion imaging, tomographic (SPECT) (including attenuation correction, qualitative or quantitative wall motion, ejection fraction by first pass or gated technique, additional quantification, when performed); multiple studies, at rest and/or stress (exercise or pharmacologic) and/or redistribution and/or rest reinjection | 78 | $0 |
| New patient visit (30+ min) | 55 | $0 |
| Bmi is documented within normal parameters and no follow-up plan is required | 13 | $0 |
2018
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 436 | $11,249 |
| Return visit (30+ min) | 725 | $5,729 |
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 360 | $1,137 |
| Short return visit (20+ min) | 358 | $1,042 |
| Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) | 69 | $1,009 |
| CARDIOVASCULAR STRESS TEST | 259 | $699 |
| New patient visit (45+ min) | 54 | $332 |
| Tc99m sestamibi | 115 | $16 |
| TOBACCO NON-USER | 109 | $0 |
| Patient screened for tobacco use and received tobacco cessation intervention (counseling, pharmacotherapy, or both), if identified as a tobacco user (PV, CAD) | 56 | $0 |
| Radiologic examination, chest; single view | 114 | $0 |
| Myocardial perfusion imaging, tomographic (SPECT) (including attenuation correction, qualitative or quantitative wall motion, ejection fraction by first pass or gated technique, additional quantification, when performed); multiple studies, at rest and/or stress (exercise or pharmacologic) and/or redistribution and/or rest reinjection | 113 | $0 |
Drugs they prescribed that Part D paid
$2,042,038
Pharmacies billed $2,042,038 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 7,818) in 2024. At or below the middle of the specialty; the typical cardiology clinician is at 0%.
5,731 generic and 2,087 brand-name prescriptions · $2,042,038 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Eliquis | 730 | $727,373 | $996 |
| Xarelto | 329 | $297,433 | $904 |
| Entresto | 187 | $225,564 | $1,206 |
| Jardiance | 127 | $146,993 | $1,157 |
| Farxiga | 129 | $126,830 | $983 |
See all 49 drugs
| Eliquis | 730 | $727,373 | $996 |
| Xarelto | 329 | $297,433 | $904 |
| Entresto | 187 | $225,564 | $1,206 |
| Jardiance | 127 | $146,993 | $1,157 |
| Farxiga | 129 | $126,830 | $983 |
| Vascepa | 163 | $102,861 | $631 |
| Brilinta | 109 | $64,457 | $591 |
| Repatha Sureclick | 69 | $50,064 | $726 |
| Verquvo | 41 | $44,026 | $1,074 |
| Rybelsus | 17 | $37,879 | $2,228 |
| Icosapent Ethyl | 83 | $36,274 | $437 |
| Synjardy Xr | 40 | $26,826 | $671 |
| Ozempic | 26 | $23,986 | $923 |
| Olmesartan-Hydrochlorothiazide | 373 | $17,555 | $47 |
| Metoprolol | 830 | $12,730 | $15 |
| Dapagliflozin | 17 | $11,282 | $664 |
| Rosuvastatin | 620 | $9,759 | $16 |
| Ranolazine Er | 96 | $9,387 | $98 |
| Ezetimibe | 306 | $7,964 | $26 |
| Atorvastatin | 579 | $6,749 | $12 |
| Olmesartan Medoxomil | 406 | $6,339 | $16 |
| Clopidogrel | 322 | $4,250 | $13 |
| Amlodipine Besylate | 462 | $3,517 | $8 |
| Amlodipine-Olmesartan | 41 | $3,515 | $86 |
| Nitroglycerin | 348 | $2,854 | $8 |
| Potassium Chloride | 103 | $2,212 | $21 |
| Olmesartan-Amlodipine-Hctz | 18 | $2,206 | $123 |
| Isosorbide Mononitrate Er | 137 | $1,877 | $14 |
| Amiodarone | 17 | $1,469 | $86 |
| Losartan | 168 | $1,456 | $9 |
| Metoprolol | 109 | $960 | $9 |
| Carvedilol | 105 | $947 | $9 |
| Hydralazine | 48 | $940 | $20 |
| Warfarin | 65 | $862 | $13 |
| Losartan-Hydrochlorothiazide | 32 | $854 | $27 |
| Clonidine | 80 | $785 | $10 |
| Furosemide | 91 | $689 | $8 |
| Valsartan | 24 | $561 | $23 |
| Diltiazem 24hr Er (Cd) | 14 | $427 | $30 |
| Lorazepam | 31 | $416 | $13 |
| Chlorthalidone | 26 | $411 | $16 |
| Omega-3 Acid Ethyl Esters | 18 | $397 | $22 |
| Baclofen | 12 | $350 | $29 |
| Klor-Con 10 | 19 | $317 | $17 |
| Famotidine | 25 | $307 | $12 |
| Irbesartan | 12 | $304 | $25 |
| Lisinopril | 20 | $128 | $6 |
| Spironolactone | 14 | $117 | $8 |
| Hydrochlorothiazide | 24 | $87 | $4 |
Year by year
| 2024 | 7,818 | 1,135 | 0% (0) | 27% | $2,042,038 |
| 2023 | 7,644 | 1,126 | 0% (0) | 28% | $2,615,756 |
| 2022 | 7,381 | 1,053 | 0% (0) | None | $2,275,647 |
| 2021 | 9,472 | 1,134 | 0% (0) | 32% | $2,138,200 |
| 2020 | 11,843 | 1,235 | 0% (0) | None | $2,284,464 |
| 2019 | 12,619 | 1,354 | 0% (0) | 32% | $1,925,550 |
| 2018 | 10,924 | 1,184 | None | 16% | $859,258 |
| 2017 | 10,567 | 1,083 | None | 18% | $676,599 |
| 2016 | 10,254 | 1,002 | None | 20% | $576,823 |
| 2015 | 8,152 | 849 | None | 24% | $409,553 |
| 2014 | 7,575 | 788 | None | None | $365,639 |
| 2013 | 6,538 | 683 | 0% (27) | None | $345,393 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 46 drugs
| Eliquis | 696 | $838,381 | $1,205 |
| Xarelto | 304 | $327,517 | $1,077 |
| Entresto | 194 | $270,075 | $1,392 |
| Farxiga | 169 | $216,555 | $1,281 |
| Vascepa | 249 | $207,586 | $834 |
| Jardiance | 127 | $200,077 | $1,575 |
| Brilinta | 86 | $81,329 | $946 |
| Rybelsus | 29 | $78,270 | $2,699 |
| Synjardy Xr | 44 | $43,325 | $985 |
| Ozempic | 27 | $33,975 | $1,258 |
| Icosapent Ethyl | 45 | $28,475 | $633 |
| Ranolazine Er | 90 | $27,944 | $310 |
| Verquvo | 23 | $24,262 | $1,055 |
| Metoprolol | 837 | $23,382 | $28 |
| Repatha Sureclick | 37 | $23,209 | $627 |
| Olmesartan-Hydrochlorothiazide | 246 | $21,238 | $86 |
| Rosuvastatin | 573 | $20,052 | $35 |
| Ezetimibe | 263 | $18,750 | $71 |
| Atorvastatin | 592 | $15,613 | $26 |
| Olmesartan Medoxomil | 253 | $14,190 | $56 |
| Amlodipine Besylate | 511 | $10,486 | $21 |
| Clopidogrel | 319 | $8,351 | $26 |
| Isosorbide Mononitrate Er | 133 | $5,929 | $45 |
| Nitroglycerin | 304 | $5,747 | $19 |
| Losartan | 224 | $5,586 | $25 |
| Potassium Chloride | 132 | $5,386 | $41 |
| Amlodipine-Olmesartan | 26 | $3,478 | $134 |
| Metoprolol | 141 | $2,735 | $19 |
| Amiodarone | 33 | $2,676 | $81 |
| Carvedilol | 137 | $2,665 | $19 |
| Chlorthalidone | 48 | $2,355 | $49 |
| Clonidine | 95 | $1,816 | $19 |
| Losartan-Hydrochlorothiazide | 55 | $1,682 | $31 |
| Diltiazem 24hr Er (Cd) | 23 | $1,554 | $68 |
| Valsartan | 19 | $1,513 | $80 |
| Warfarin | 54 | $1,441 | $27 |
| Klor-Con 10 | 26 | $1,164 | $45 |
| Hydralazine | 38 | $1,138 | $30 |
| Furosemide | 103 | $1,021 | $10 |
| Irbesartan | 16 | $818 | $51 |
| Metformin | 13 | $397 | $31 |
| Hydrochlorothiazide | 32 | $353 | $11 |
| Lisinopril | 16 | $259 | $16 |
| Baclofen | 13 | $255 | $20 |
| Famotidine | 17 | $163 | $10 |
| Lorazepam | 29 | $135 | $5 |
2022: 48 drugs
| Eliquis | 707 | $756,724 | $1,070 |
| Xarelto | 336 | $307,552 | $915 |
| Vascepa | 373 | $248,203 | $665 |
| Entresto | 193 | $234,691 | $1,216 |
| Jardiance | 108 | $150,077 | $1,390 |
| Farxiga | 107 | $118,142 | $1,104 |
| Rybelsus | 33 | $70,796 | $2,145 |
| Brilinta | 43 | $39,961 | $929 |
| Synjardy Xr | 39 | $38,567 | $989 |
| Repatha Sureclick | 46 | $31,773 | $691 |
| Icosapent Ethyl | 54 | $26,647 | $493 |
| Ranolazine Er | 95 | $25,663 | $270 |
| Pradaxa | 19 | $23,184 | $1,220 |
| Ezetimibe | 188 | $22,668 | $121 |
| Rosuvastatin | 348 | $19,799 | $57 |
| Metoprolol | 771 | $17,316 | $22 |
| Ozempic | 19 | $17,301 | $911 |
| Atorvastatin | 707 | $12,873 | $18 |
| Olmesartan Medoxomil | 140 | $10,217 | $73 |
| Clopidogrel | 340 | $9,633 | $28 |
| Nitroglycerin | 328 | $6,021 | $18 |
| Potassium Chloride | 150 | $5,707 | $38 |
| Amlodipine Besylate | 458 | $5,200 | $11 |
| Olmesartan-Hydrochlorothiazide | 50 | $4,984 | $100 |
| Losartan | 269 | $4,468 | $17 |
| Chlorthalidone | 90 | $3,957 | $44 |
| Isosorbide Mononitrate Er | 134 | $3,372 | $25 |
| Amiodarone | 65 | $3,281 | $50 |
| Valsartan | 30 | $2,815 | $94 |
| Omega-3 Acid Ethyl Esters | 14 | $2,712 | $194 |
| Carvedilol | 175 | $2,694 | $15 |
| Metoprolol | 196 | $2,490 | $13 |
| Losartan-Hydrochlorothiazide | 63 | $1,747 | $28 |
| Warfarin | 73 | $1,544 | $21 |
| Clonidine | 84 | $1,483 | $18 |
| Irbesartan | 22 | $1,042 | $47 |
| Furosemide | 107 | $882 | $8 |
| Diltiazem 24hr Er (Cd) | 20 | $857 | $43 |
| Valsartan-Hydrochlorothiazide | 11 | $856 | $78 |
| Klor-Con 10 | 28 | $836 | $30 |
| Hydralazine | 21 | $499 | $24 |
| Hydrochlorothiazide | 37 | $397 | $11 |
| Lisinopril | 29 | $321 | $11 |
| Pravastatin | 11 | $225 | $20 |
| Lorazepam | 31 | $175 | $6 |
| Baclofen | 12 | $121 | $10 |
| Metformin | 11 | $111 | $10 |
| Famotidine | 12 | $69 | $6 |
2021: 55 drugs
| Eliquis | 909 | $630,744 | $694 |
| Vascepa | 699 | $338,844 | $485 |
| Xarelto | 411 | $307,278 | $748 |
| Entresto | 193 | $176,599 | $915 |
| Jardiance | 163 | $173,258 | $1,063 |
| Farxiga | 62 | $63,255 | $1,020 |
| Rybelsus | 46 | $59,771 | $1,299 |
| Icosapent Ethyl | 98 | $39,318 | $401 |
| Brilinta | 56 | $39,158 | $699 |
| Synjardy Xr | 63 | $38,219 | $607 |
| Pradaxa | 36 | $37,644 | $1,046 |
| Ranolazine Er | 175 | $30,175 | $172 |
| Metoprolol | 822 | $17,432 | $21 |
| Atorvastatin | 987 | $16,212 | $16 |
| Repatha Sureclick | 24 | $15,341 | $639 |
| Praluent | 15 | $15,134 | $1,009 |
| Rosuvastatin | 262 | $14,892 | $57 |
| Ezetimibe | 152 | $13,445 | $88 |
| Olmesartan Medoxomil | 143 | $11,441 | $80 |
| Nitroglycerin | 359 | $9,443 | $26 |
| Chlorthalidone | 179 | $7,182 | $40 |
| Potassium Chloride | 275 | $6,572 | $24 |
| Invokana | 12 | $6,348 | $529 |
| Amlodipine Besylate | 593 | $5,616 | $9 |
| Losartan | 396 | $5,315 | $13 |
| Clopidogrel | 372 | $4,838 | $13 |
| Isosorbide Mononitrate Er | 186 | $4,018 | $22 |
| Olmesartan-Hydrochlorothiazide | 44 | $3,201 | $73 |
| Metoprolol | 281 | $2,990 | $11 |
| Carvedilol | 235 | $2,919 | $12 |
| Amiodarone | 59 | $2,539 | $43 |
| Valsartan | 43 | $2,449 | $57 |
| Losartan-Hydrochlorothiazide | 88 | $2,396 | $27 |
| Clonidine | 162 | $1,514 | $9 |
| Warfarin | 69 | $1,412 | $20 |
| Furosemide | 198 | $1,408 | $7 |
| Diltiazem 24hr Er (Cd) | 28 | $1,305 | $47 |
| Dilt-Xr | 16 | $1,093 | $68 |
| Midodrine | 12 | $1,055 | $88 |
| Klor-Con 10 | 29 | $754 | $26 |
| Irbesartan | 24 | $729 | $30 |
| Hydralazine | 53 | $591 | $11 |
| Propafenone | 11 | $539 | $49 |
| Irbesartan-Hydrochlorothiazide | 13 | $527 | $41 |
| Lisinopril | 47 | $498 | $11 |
| Hydrochlorothiazide | 44 | $497 | $11 |
| Baclofen | 12 | $382 | $32 |
| Pravastatin | 12 | $243 | $20 |
| Klor-Con 8 | 14 | $229 | $16 |
| Lorazepam | 23 | $214 | $9 |
| Meclizine | 16 | $213 | $13 |
| Benazepril | 15 | $163 | $11 |
| Omeprazole | 11 | $125 | $11 |
| Metformin | 13 | $118 | $9 |
| Famotidine | 12 | $68 | $6 |
2020: 60 drugs
| Vascepa | 1,351 | $593,434 | $439 |
| Eliquis | 840 | $478,027 | $569 |
| Xarelto | 496 | $313,977 | $633 |
| Jardiance | 275 | $250,956 | $913 |
| Entresto | 192 | $136,234 | $710 |
| Synjardy Xr | 154 | $92,328 | $600 |
| Brilinta | 139 | $65,352 | $470 |
| Pradaxa | 79 | $55,385 | $701 |
| Rybelsus | 31 | $30,337 | $979 |
| Ranolazine Er | 181 | $26,067 | $144 |
| Farxiga | 30 | $21,583 | $719 |
| Metoprolol | 986 | $18,923 | $19 |
| Rosuvastatin | 309 | $18,517 | $60 |
| Atorvastatin | 1,220 | $16,182 | $13 |
| Nitroglycerin | 489 | $11,255 | $23 |
| Ezetimibe | 170 | $11,024 | $65 |
| Chlorthalidone | 232 | $10,356 | $45 |
| Repatha Sureclick | 16 | $9,785 | $612 |
| Potassium Chloride | 287 | $5,565 | $19 |
| Repatha | 12 | $5,250 | $437 |
| Losartan | 473 | $5,152 | $11 |
| Olmesartan Medoxomil | 144 | $5,136 | $36 |
| Losartan-Hydrochlorothiazide | 87 | $5,093 | $59 |
| Amiodarone | 86 | $4,804 | $56 |
| Clopidogrel | 452 | $4,525 | $10 |
| Amlodipine Besylate | 753 | $4,178 | $6 |
| Isosorbide Mononitrate Er | 222 | $3,356 | $15 |
| Omega-3 Acid Ethyl Esters | 18 | $3,243 | $180 |
| Metoprolol | 389 | $2,495 | $6 |
| Carvedilol | 338 | $2,423 | $7 |
| Midodrine | 26 | $2,152 | $83 |
| Valsartan | 41 | $1,956 | $48 |
| Olmesartan-Hydrochlorothiazide | 30 | $1,802 | $60 |
| Irbesartan | 41 | $1,724 | $42 |
| Valsartan-Hydrochlorothiazide | 18 | $1,578 | $88 |
| Warfarin | 106 | $1,469 | $14 |
| Clonidine | 137 | $1,255 | $9 |
| Dilt-Xr | 17 | $1,075 | $63 |
| Diltiazem 24hr Er (Cd) | 30 | $877 | $29 |
| Hydrochlorothiazide | 82 | $840 | $10 |
| Furosemide | 196 | $823 | $4 |
| Olopatadine | 13 | $787 | $61 |
| Propafenone | 23 | $571 | $25 |
| Hydralazine | 44 | $523 | $12 |
| Meclizine | 19 | $425 | $22 |
| Baclofen | 12 | $391 | $33 |
| Lisinopril | 54 | $375 | $7 |
| Pravastatin | 21 | $357 | $17 |
| Felodipine Er | 15 | $253 | $17 |
| Lorazepam | 24 | $221 | $9 |
| Irbesartan-Hydrochlorothiazide | 15 | $202 | $13 |
| Glimepiride | 23 | $173 | $8 |
| Klor-Con 10 | 12 | $152 | $13 |
| Verapamil | 11 | $134 | $12 |
| Metformin | 27 | $128 | $5 |
| Benazepril | 23 | $127 | $6 |
| Omeprazole | 14 | $86 | $6 |
| Spironolactone | 15 | $74 | $5 |
| Famotidine | 12 | $67 | $6 |
| Ramipril | 11 | $37 | $3 |
2019: 60 drugs
| Vascepa | 1,418 | $466,594 | $329 |
| Eliquis | 727 | $376,428 | $518 |
| Jardiance | 417 | $290,387 | $696 |
| Xarelto | 507 | $286,419 | $565 |
| Entresto | 145 | $83,011 | $572 |
| Brilinta | 148 | $65,884 | $445 |
| Synjardy Xr | 121 | $54,368 | $449 |
| Pradaxa | 88 | $45,019 | $512 |
| Ranolazine Er | 152 | $27,991 | $184 |
| Ranexa | 56 | $24,879 | $444 |
| Metoprolol | 968 | $23,470 | $24 |
| Atorvastatin | 1,428 | $20,722 | $15 |
| Rosuvastatin | 332 | $13,757 | $41 |
| Nitroglycerin | 518 | $11,286 | $22 |
| Chlorthalidone | 253 | $8,769 | $35 |
| Ezetimibe | 123 | $8,265 | $67 |
| Farxiga | 12 | $7,986 | $665 |
| Invokana | 15 | $7,280 | $485 |
| Potassium Chloride | 288 | $6,228 | $22 |
| Amlodipine Besylate | 857 | $5,877 | $7 |
| Clopidogrel | 525 | $4,955 | $9 |
| Amiodarone | 89 | $4,579 | $51 |
| Olmesartan Medoxomil | 46 | $4,385 | $95 |
| Losartan | 491 | $4,127 | $8 |
| Omega-3 Acid Ethyl Esters | 26 | $3,863 | $149 |
| Metoprolol | 571 | $3,529 | $6 |
| Carvedilol | 353 | $3,277 | $9 |
| Isosorbide Mononitrate Er | 203 | $3,114 | $15 |
| Warfarin | 203 | $2,546 | $13 |
| Prasugrel | 14 | $1,952 | $139 |
| Losartan-Hydrochlorothiazide | 151 | $1,939 | $13 |
| Irbesartan | 67 | $1,843 | $28 |
| Valsartan | 48 | $1,751 | $36 |
| Valsartan-Hydrochlorothiazide | 33 | $1,493 | $45 |
| Clonidine | 127 | $1,240 | $10 |
| Furosemide | 243 | $1,176 | $5 |
| Dilt-Xr | 18 | $1,041 | $58 |
| Midodrine | 19 | $990 | $52 |
| Hydralazine | 61 | $878 | $14 |
| Cartia Xt | 19 | $641 | $34 |
| Diltiazem 24hr Er (Cd) | 21 | $545 | $26 |
| Baclofen | 12 | $516 | $43 |
| Meclizine | 21 | $491 | $23 |
| Lisinopril | 83 | $476 | $6 |
| Hydrochlorothiazide | 49 | $461 | $9 |
| Propafenone | 19 | $436 | $23 |
| Digoxin | 11 | $418 | $38 |
| Cilostazol | 24 | $376 | $16 |
| Pravastatin | 19 | $361 | $19 |
| Irbesartan-Hydrochlorothiazide | 15 | $348 | $23 |
| Doxazosin Mesylate | 11 | $318 | $29 |
| Ramipril | 11 | $300 | $27 |
| Lorazepam | 32 | $259 | $8 |
| Benazepril | 24 | $236 | $10 |
| Omeprazole | 21 | $205 | $10 |
| Verapamil Er | 11 | $166 | $15 |
| Spironolactone | 17 | $129 | $8 |
| Metformin | 25 | $105 | $4 |
| Famotidine | 12 | $66 | $6 |
| Atenolol | 14 | $61 | $4 |
2018: 57 drugs
| Xarelto | 472 | $228,750 | $485 |
| Eliquis | 396 | $192,378 | $486 |
| Brilinta | 190 | $69,189 | $364 |
| Ranexa | 148 | $60,414 | $408 |
| Pradaxa | 89 | $46,355 | $521 |
| Jardiance | 60 | $45,293 | $755 |
| Atorvastatin | 1,706 | $23,368 | $14 |
| Ezetimibe | 85 | $17,884 | $210 |
| Metoprolol | 716 | $15,092 | $21 |
| Entresto | 23 | $14,932 | $649 |
| Vascepa | 37 | $11,179 | $302 |
| Nitroglycerin | 445 | $10,302 | $23 |
| Rosuvastatin | 217 | $8,697 | $40 |
| Omega-3 Acid Ethyl Esters | 62 | $8,348 | $135 |
| Potassium Chloride | 188 | $7,180 | $38 |
| Amiodarone | 111 | $6,891 | $62 |
| Chlorthalidone | 201 | $6,802 | $34 |
| Prasugrel | 22 | $6,243 | $284 |
| Amlodipine Besylate | 977 | $5,912 | $6 |
| Clopidogrel | 590 | $5,530 | $9 |
| Metoprolol | 827 | $4,795 | $6 |
| Losartan | 563 | $4,738 | $8 |
| Warfarin | 325 | $4,572 | $14 |
| Isosorbide Mononitrate Er | 296 | $4,417 | $15 |
| Carvedilol | 436 | $3,607 | $8 |
| Valsartan | 89 | $3,304 | $37 |
| Losartan-Hydrochlorothiazide | 252 | $3,062 | $12 |
| Olmesartan Medoxomil | 41 | $2,737 | $67 |
| Clonidine | 198 | $1,426 | $7 |
| Diltiazem 24hr Er (Cd) | 50 | $1,090 | $22 |
| Hydralazine | 75 | $989 | $13 |
| Furosemide | 229 | $987 | $4 |
| Cartia Xt | 13 | $969 | $75 |
| Valsartan-Hydrochlorothiazide | 18 | $702 | $39 |
| Dilt-Xr | 17 | $687 | $40 |
| Lisinopril | 96 | $670 | $7 |
| Fenofibrate | 14 | $643 | $46 |
| Hydrochlorothiazide | 54 | $546 | $10 |
| Propafenone | 11 | $540 | $49 |
| Pravastatin | 23 | $476 | $21 |
| Cilostazol | 37 | $412 | $11 |
| Meclizine | 23 | $356 | $15 |
| Baclofen | 12 | $351 | $29 |
| Verapamil Er | 14 | $351 | $25 |
| Felodipine Er | 17 | $343 | $20 |
| Doxazosin Mesylate | 16 | $293 | $18 |
| Enalapril Maleate | 13 | $264 | $20 |
| Lorazepam | 32 | $243 | $8 |
| Benazepril | 37 | $219 | $6 |
| Omeprazole | 24 | $209 | $9 |
| Atenolol | 21 | $203 | $10 |
| Spironolactone | 24 | $190 | $8 |
| Klor-Con 10 | 11 | $154 | $14 |
| Lisinopril-Hydrochlorothiazide | 12 | $70 | $6 |
| Famotidine | 12 | $67 | $6 |
| Prednisone | 14 | $66 | $5 |
| Alprazolam | 11 | $45 | $4 |
2017: 53 drugs
| Xarelto | 316 | $136,932 | $433 |
| Eliquis | 313 | $136,403 | $436 |
| Pradaxa | 154 | $64,631 | $420 |
| Brilinta | 124 | $43,809 | $353 |
| Jardiance | 90 | $40,512 | $450 |
| Ranexa | 101 | $38,321 | $379 |
| Atorvastatin | 1,954 | $24,510 | $13 |
| Effient | 43 | $19,512 | $454 |
| Benicar | 33 | $16,212 | $491 |
| Zetia | 35 | $15,903 | $454 |
| Omega-3 Acid Ethyl Esters | 68 | $10,016 | $147 |
| Potassium Chloride | 144 | $9,092 | $63 |
| Nitroglycerin | 357 | $8,467 | $24 |
| Ezetimibe | 32 | $7,056 | $220 |
| Vascepa | 12 | $6,160 | $513 |
| Rosuvastatin | 98 | $6,053 | $62 |
| Crestor | 15 | $5,517 | $368 |
| Amlodipine Besylate | 1,087 | $5,330 | $5 |
| Valsartan | 138 | $5,137 | $37 |
| Warfarin | 512 | $5,113 | $10 |
| Metoprolol | 219 | $4,907 | $22 |
| Olmesartan Medoxomil | 25 | $4,846 | $194 |
| Metoprolol | 961 | $4,755 | $5 |
| Chlorthalidone | 144 | $4,047 | $28 |
| Clopidogrel | 469 | $4,030 | $9 |
| Losartan | 558 | $3,542 | $6 |
| Isosorbide Mononitrate Er | 265 | $3,338 | $13 |
| Carvedilol | 530 | $3,251 | $6 |
| Amiodarone | 68 | $3,117 | $46 |
| Losartan-Hydrochlorothiazide | 280 | $3,008 | $11 |
| Valsartan-Hydrochlorothiazide | 63 | $1,748 | $28 |
| Nitrostat | 45 | $1,440 | $32 |
| Clonidine | 203 | $1,299 | $6 |
| Hydrochlorothiazide | 100 | $1,083 | $11 |
| Digoxin | 15 | $947 | $63 |
| Hydralazine | 79 | $895 | $11 |
| Furosemide | 243 | $847 | $3 |
| Propafenone | 29 | $832 | $29 |
| Amlodipine Besylate-Benazepril | 20 | $766 | $38 |
| Fenofibrate | 20 | $761 | $38 |
| Pravastatin | 37 | $708 | $19 |
| Lisinopril | 88 | $647 | $7 |
| Cartia Xt | 19 | $574 | $30 |
| Baclofen | 11 | $318 | $29 |
| Atenolol | 51 | $312 | $6 |
| Diltiazem 24hr Cd | 18 | $310 | $17 |
| Felodipine Er | 14 | $263 | $19 |
| Benazepril | 34 | $204 | $6 |
| Lorazepam | 29 | $184 | $6 |
| Meclizine | 11 | $165 | $15 |
| Omeprazole | 14 | $116 | $8 |
| Spironolactone | 15 | $88 | $6 |
| Famotidine | 11 | $57 | $5 |
2016: 57 drugs
| Eliquis | 268 | $99,099 | $370 |
| Pradaxa | 194 | $74,641 | $385 |
| Xarelto | 153 | $63,555 | $415 |
| Ranexa | 121 | $40,348 | $333 |
| Effient | 74 | $32,350 | $437 |
| Brilinta | 93 | $32,114 | $345 |
| Crestor | 70 | $31,983 | $457 |
| Benicar | 79 | $28,357 | $359 |
| Zetia | 88 | $27,353 | $311 |
| Atorvastatin | 1,538 | $18,639 | $12 |
| Omega-3 Acid Ethyl Esters | 73 | $15,016 | $206 |
| Nitrostat | 319 | $10,964 | $34 |
| Azor | 16 | $6,929 | $433 |
| Valsartan | 159 | $5,651 | $36 |
| Warfarin | 604 | $5,536 | $9 |
| Amlodipine Besylate | 1,171 | $5,258 | $4 |
| Metoprolol | 926 | $4,886 | $5 |
| Clopidogrel | 486 | $4,726 | $10 |
| Benicar Hct | 13 | $4,005 | $308 |
| Losartan | 550 | $3,682 | $7 |
| Carvedilol | 607 | $3,668 | $6 |
| Metoprolol | 145 | $3,447 | $24 |
| Isosorbide Mononitrate Er | 282 | $3,077 | $11 |
| Chlorthalidone | 122 | $3,026 | $25 |
| Amiodarone | 65 | $2,914 | $45 |
| Potassium Chloride | 137 | $2,649 | $19 |
| Losartan-Hydrochlorothiazide | 193 | $1,984 | $10 |
| Valsartan-Hydrochlorothiazide | 88 | $1,929 | $22 |
| Rosuvastatin | 18 | $1,821 | $101 |
| Nitroglycerin | 69 | $1,746 | $25 |
| Pravastatin | 67 | $1,249 | $19 |
| Clonidine | 189 | $1,187 | $6 |
| Niacin Er | 12 | $1,059 | $88 |
| Digoxin | 17 | $1,028 | $60 |
| Lisinopril | 138 | $1,004 | $7 |
| Benazepril-Hydrochlorothiazide | 11 | $957 | $87 |
| Fenofibrate | 23 | $915 | $40 |
| Hydrochlorothiazide | 97 | $875 | $9 |
| Propafenone | 33 | $862 | $26 |
| Hydralazine | 69 | $742 | $11 |
| Amlodipine Besylate-Benazepril | 20 | $692 | $35 |
| Cartia Xt | 16 | $665 | $42 |
| Furosemide | 212 | $608 | $3 |
| Simvastatin | 118 | $554 | $5 |
| Diltiazem Er | 16 | $397 | $25 |
| Felodipine Er | 20 | $389 | $19 |
| Bumetanide | 17 | $369 | $22 |
| Benazepril | 52 | $356 | $7 |
| Diltiazem 24hr Cd | 22 | $334 | $15 |
| Diltiazem 24hr Er | 20 | $263 | $13 |
| Diltiazem | 14 | $236 | $17 |
| Baclofen | 11 | $208 | $19 |
| Meclizine | 12 | $204 | $17 |
| Atenolol | 69 | $196 | $3 |
| Lorazepam | 20 | $82 | $4 |
| Lisinopril-Hydrochlorothiazide | 15 | $53 | $4 |
| Famotidine | 12 | $44 | $4 |
2015: 57 drugs
| Eliquis | 171 | $57,233 | $335 |
| Pradaxa | 157 | $54,840 | $349 |
| Xarelto | 123 | $46,680 | $380 |
| Effient | 85 | $30,902 | $364 |
| Crestor | 76 | $25,015 | $329 |
| Zetia | 73 | $20,553 | $282 |
| Ranexa | 72 | $20,318 | $282 |
| Omega-3 Acid Ethyl Esters | 99 | $16,903 | $171 |
| Brilinta | 43 | $16,752 | $390 |
| Atorvastatin | 592 | $8,099 | $14 |
| Nitrostat | 276 | $7,825 | $28 |
| Benicar | 28 | $7,616 | $272 |
| Clopidogrel | 544 | $6,045 | $11 |
| Valsartan | 103 | $5,829 | $57 |
| Warfarin | 506 | $5,075 | $10 |
| Azor | 13 | $4,642 | $357 |
| Amlodipine Besylate | 1,013 | $4,359 | $4 |
| Metoprolol | 141 | $4,081 | $29 |
| Metoprolol | 704 | $3,671 | $5 |
| Lovaza | 17 | $3,667 | $216 |
| Carvedilol | 617 | $3,663 | $6 |
| Fenofibrate | 36 | $3,567 | $99 |
| Lantus | 14 | $3,518 | $251 |
| Amiodarone | 92 | $3,462 | $38 |
| Diovan | 12 | $2,957 | $246 |
| Losartan | 400 | $2,875 | $7 |
| Isosorbide Mononitrate Er | 246 | $2,867 | $12 |
| Valsartan-Hydrochlorothiazide | 77 | $2,009 | $26 |
| Potassium Chloride | 98 | $1,924 | $20 |
| Niacin Er | 14 | $1,540 | $110 |
| Digoxin | 26 | $1,379 | $53 |
| Simvastatin | 269 | $1,294 | $5 |
| Losartan-Hydrochlorothiazide | 137 | $1,214 | $9 |
| Pravastatin | 59 | $1,204 | $20 |
| Bystolic | 11 | $1,063 | $97 |
| Benazepril-Hydrochlorothiazide | 12 | $1,017 | $85 |
| Hydrochlorothiazide | 105 | $912 | $9 |
| Propafenone | 33 | $804 | $24 |
| Cartia Xt | 30 | $780 | $26 |
| Lisinopril | 151 | $756 | $5 |
| Chlorthalidone | 33 | $726 | $22 |
| Clonidine | 128 | $680 | $5 |
| Diltiazem 24hr Cd | 28 | $641 | $23 |
| Amlodipine Besylate-Benazepril | 20 | $632 | $32 |
| Furosemide | 189 | $534 | $3 |
| Hydralazine | 51 | $518 | $10 |
| Diltiazem 24hr Er | 15 | $345 | $23 |
| Benazepril | 48 | $283 | $6 |
| Allopurinol | 15 | $220 | $15 |
| Baclofen | 12 | $193 | $16 |
| Atenolol | 55 | $189 | $3 |
| Pantoprazole | 20 | $144 | $7 |
| Lorazepam | 23 | $89 | $4 |
| Metformin | 19 | $73 | $4 |
| Lisinopril-Hydrochlorothiazide | 12 | $66 | $6 |
| Famotidine | 12 | $44 | $4 |
| Lovastatin | 12 | $39 | $3 |
2014: 61 drugs
| Xarelto | 115 | $34,829 | $303 |
| Crestor | 111 | $30,613 | $276 |
| Lovaza | 152 | $29,769 | $196 |
| Diovan | 161 | $28,559 | $177 |
| Eliquis | 93 | $27,459 | $295 |
| Zetia | 80 | $18,218 | $228 |
| Effient | 67 | $17,996 | $269 |
| Pradaxa | 58 | $17,174 | $296 |
| Brilinta | 59 | $16,058 | $272 |
| Ranexa | 49 | $12,795 | $261 |
| Nitrostat | 340 | $9,804 | $29 |
| Atorvastatin | 526 | $7,199 | $14 |
| Clopidogrel | 508 | $7,144 | $14 |
| Benicar | 22 | $5,485 | $249 |
| Amlodipine Besylate | 807 | $4,824 | $6 |
| Carvedilol | 537 | $4,820 | $9 |
| Metoprolol | 135 | $3,818 | $28 |
| Isosorbide Mononitrate Er | 237 | $3,800 | $16 |
| Warfarin | 463 | $3,783 | $8 |
| Valsartan-Hydrochlorothiazide | 77 | $3,600 | $47 |
| Januvia | 12 | $3,454 | $288 |
| Niacin Er | 19 | $3,407 | $179 |
| Metoprolol | 539 | $3,186 | $6 |
| Lantus | 14 | $3,076 | $220 |
| Omega-3 Acid Ethyl Esters | 19 | $3,012 | $159 |
| Fenofibrate | 19 | $2,347 | $124 |
| Losartan | 249 | $2,340 | $9 |
| Amiodarone | 72 | $2,274 | $32 |
| Dexilant | 12 | $2,221 | $185 |
| Simvastatin | 356 | $2,053 | $6 |
| Amlodipine Besylate-Benazepril | 41 | $1,937 | $47 |
| Potassium Chloride | 85 | $1,811 | $21 |
| Benicar Hct | 11 | $1,804 | $164 |
| Digoxin | 25 | $1,403 | $56 |
| Nateglinide | 12 | $1,361 | $113 |
| Hydrochlorothiazide | 145 | $1,180 | $8 |
| Propafenone | 53 | $1,053 | $20 |
| Losartan-Hydrochlorothiazide | 96 | $973 | $10 |
| Pravastatin | 41 | $902 | $22 |
| Benazepril | 108 | $784 | $7 |
| Clonidine | 107 | $704 | $7 |
| Proair Hfa | 12 | $690 | $57 |
| Nifedipine Er | 18 | $680 | $38 |
| Furosemide | 206 | $647 | $3 |
| Digox | 14 | $622 | $44 |
| Lisinopril | 132 | $609 | $5 |
| Diltiazem 24hr Cd | 17 | $602 | $35 |
| Cartia Xt | 14 | $452 | $32 |
| Diltiazem Er | 15 | $346 | $23 |
| Meclizine | 13 | $335 | $26 |
| Chlorthalidone | 17 | $323 | $19 |
| Diltiazem 24hr Er | 17 | $239 | $14 |
| Baclofen | 12 | $191 | $16 |
| Metformin | 20 | $131 | $7 |
| Lorazepam | 22 | $123 | $6 |
| Atenolol | 34 | $119 | $4 |
| Pantoprazole | 13 | $114 | $9 |
| Alprazolam | 29 | $105 | $4 |
| Lovastatin | 16 | $102 | $6 |
| Lisinopril-Hydrochlorothiazide | 14 | $77 | $6 |
| Famotidine | 13 | $67 | $5 |
2013: 64 drugs
| Diovan | 162 | $29,511 | $182 |
| Lovaza | 170 | $28,645 | $169 |
| Crestor | 105 | $27,519 | $262 |
| Clopidogrel | 435 | $27,486 | $63 |
| Xarelto | 90 | $24,448 | $272 |
| Zetia | 111 | $23,099 | $208 |
| Effient | 81 | $18,322 | $226 |
| Pradaxa | 65 | $16,985 | $261 |
| Brilinta | 43 | $10,478 | $244 |
| Atorvastatin | 393 | $9,519 | $24 |
| Nitrostat | 312 | $7,582 | $24 |
| Niaspan | 50 | $7,445 | $149 |
| Valsartan-Hydrochlorothiazide | 64 | $6,956 | $109 |
| Azor | 22 | $5,736 | $261 |
| Carvedilol | 476 | $4,926 | $10 |
| Aggrenox | 11 | $4,598 | $418 |
| Amlodipine Besylate | 540 | $4,516 | $8 |
| Metoprolol | 117 | $4,404 | $38 |
| Warfarin | 504 | $4,394 | $9 |
| Amlodipine Besylate-Benazepril | 49 | $3,711 | $76 |
| Eliquis | 13 | $3,476 | $267 |
| Diovan Hct | 13 | $3,213 | $247 |
| Simvastatin | 372 | $3,030 | $8 |
| Losartan | 184 | $3,018 | $16 |
| Plavix | 15 | $2,991 | $199 |
| Metoprolol | 397 | $2,672 | $7 |
| Isosorbide Mononitrate Er | 148 | $2,497 | $17 |
| Namenda | 14 | $2,389 | $171 |
| Lantus | 11 | $2,224 | $202 |
| Nateglinide | 24 | $2,202 | $92 |
| Benicar Hct | 17 | $1,970 | $116 |
| Nifedipine Er | 31 | $1,559 | $50 |
| Potassium Chloride | 50 | $1,541 | $31 |
| Hydrochlorothiazide | 120 | $1,269 | $11 |
| Propafenone | 41 | $1,173 | $29 |
| Acarbose | 14 | $1,169 | $83 |
| Pravastatin | 65 | $1,116 | $17 |
| Benazepril | 123 | $978 | $8 |
| Amiodarone | 54 | $914 | $17 |
| Lisinopril | 103 | $627 | $6 |
| Furosemide | 118 | $592 | $5 |
| Diltiazem 24hr Er | 24 | $554 | $23 |
| Losartan-Hydrochlorothiazide | 35 | $506 | $14 |
| Diltiazem 24hr Cd | 13 | $498 | $38 |
| Felodipine Er | 13 | $472 | $36 |
| Clonidine | 55 | $433 | $8 |
| Pioglitazone | 12 | $426 | $35 |
| Diltiazem Er | 20 | $364 | $18 |
| Meclizine | 11 | $341 | $31 |
| Lisinopril-Hydrochlorothiazide | 20 | $314 | $16 |
| Baclofen | 12 | $312 | $26 |
| Metformin | 38 | $306 | $8 |
| Digox | 31 | $259 | $8 |
| Ramipril | 12 | $231 | $19 |
| Lorazepam | 25 | $190 | $8 |
| Chlorthalidone | 19 | $183 | $10 |
| Lovastatin | 14 | $182 | $13 |
| Allopurinol | 25 | $173 | $7 |
| Alprazolam | 37 | $169 | $5 |
| Atenolol | 38 | $165 | $4 |
| Terazosin | 11 | $137 | $12 |
| Hydrocodone-Acetaminophen | 24 | $133 | $6 |
| Famotidine | 18 | $116 | $6 |
| Naproxen | 14 | $98 | $7 |
Money from drug and device companies
$1,512 in 2025
| 2025 | 10 | 47 | None | $1,512 |
| 2024 | 13 | 59 | None | $1,747 |
| 2023 | 20 | 86 | None | $2,535 |
| 2022 | 18 | 78 | $4,000 | $6,854 |
| 2021 | 12 | 39 | None | $1,643 |
| 2020 | 9 | 50 | $3,563 | $4,326 |
| 2019 | 16 | 124 | $7,350 | $13,140 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Novo Nordisk | Wegovy | $352 | 14 payments
|
| AstraZeneca Pharmaceuticals LP | Farxiga | $296 | 8 payments
|
| Bayer Healthcare Pharmaceuticals | Adempas | $239 | 4 payments
|
| Boston Scientific | Watchman Flx | $208 | 5 payments
|
| Merck Sharp & Dohme | Verquvo | $160 | 6 payments
|
| Novartis Pharmaceuticals | Leqvio | $83 | 3 payments
|
See all 47 published payments
| AstraZeneca Pharmaceuticals LP | Meals · 2025-12-18 | Farxiga | $27 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-12-13 | Kerendia | $30 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-11-20 | Eliquis | $23 |
| Merck Sharp & Dohme | Meals · 2025-11-14 | Verquvo | $30 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-11-07 | Adempas | $150 |
| Novo Nordisk | Meals · 2025-11-06 | Wegovy | $26 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-11-05 | Farxiga | $21 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-10-25 | Farxiga | $29 |
| Novo Nordisk | Meals · 2025-10-18 | Wegovy | $23 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-10-09 | Kerendia | $32 |
| Merck Sharp & Dohme | Meals · 2025-10-03 | Capvaxive | $27 |
| Abbott Laboratories | Meals · 2025-10-02 | Mitraclip | $24 |
| Novo Nordisk | Meals · 2025-09-29 | Wegovy | $6 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-09-16 | Farxiga | $135 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-09-12 | Farxiga | $26 |
| Merck Sharp & Dohme | Meals · 2025-08-22 | Verquvo | $28 |
| Novo Nordisk | Meals · 2025-08-20 | Wegovy | $26 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-08-12 | Farxiga | $14 |
| Boston Scientific | Meals · 2025-08-06 | Watchman Flx | $31 |
| Novo Nordisk | Meals · 2025-08-06 | Wegovy | $15 |
| Amgen | Meals · 2025-08-01 | Repatha | $24 |
| Merck Sharp & Dohme | Meals · 2025-07-25 | Verquvo | $25 |
| Novartis Pharmaceuticals | Meals · 2025-07-23 | Leqvio | $24 |
| Novo Nordisk | Meals · 2025-07-08 | Wegovy | $27 |
| Novo Nordisk | Meals · 2025-05-30 | Wegovy | $16 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-05-29 | Farxiga | $21 |
| Boston Scientific | Meals · 2025-05-28 | Watchman Flx | $24 |
| Novo Nordisk | Meals · 2025-05-22 | Wegovy | $18 |
| Novo Nordisk | Meals · 2025-05-01 | Wegovy | $2 |
| Novo Nordisk | Meals · 2025-05-01 | Wegovy | $10 |
| Merck Sharp & Dohme | Meals · 2025-04-30 | Verquvo | $24 |
| Novo Nordisk | Meals · 2025-04-17 | Ozempic | $28 |
| Novo Nordisk | Meals · 2025-04-17 | Wegovy | $119 |
| Amgen | Meals · 2025-04-11 | Repatha | $31 |
| Novartis Pharmaceuticals | Meals · 2025-04-04 | Leqvio | $34 |
| Novo Nordisk | Meals · 2025-03-28 | Ozempic | $17 |
| Boehringer Ingelheim Pharmaceuticals | Meals · 2025-03-21 | Jardiance | $25 |
| Boston Scientific | Meals · 2025-03-20 | Watchman Flx | $84 |
| Novo Nordisk | Meals · 2025-03-15 | Ozempic | $20 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-03-12 | Eliquis | $21 |
| Boston Scientific | Meals · 2025-03-06 | Watchman Flx | $52 |
| Merck Sharp & Dohme | Meals · 2025-02-12 | Verquvo | $27 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-02-07 | Kerendia | $26 |
| Amgen | Meals · 2025-01-24 | Repatha | $28 |
| Boston Scientific | Meals · 2025-01-22 | Watchman Flx | $17 |
| Novartis Pharmaceuticals | Meals · 2025-01-10 | Leqvio | $25 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-01-03 | Farxiga | $23 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $1,747
| E.R. Squibb & Sons L.L.C. | Camzyos | $268 | 8 payments
|
| Amgen | Repatha | $224 | 6 payments
|
| Kiniksa Pharmaceuticals International plc | Arcalyst | $209 | 8 payments
|
| Merck Sharp & Dohme | Verquvo | $199 | 8 payments
|
| Novo Nordisk | Ozempic | $195 | 6 payments
|
| AstraZeneca Pharmaceuticals LP | Farxiga | $147 | 6 payments
|
| Bayer Healthcare Pharmaceuticals | Kerendia | $103 | 4 payments
|
| Boston Scientific | Watchman Flx | $100 | 4 payments
|
| CVRx | Barostim Neo System | $89 | 1 payment
|
| Novartis Pharmaceuticals | Entresto | $89 | 3 payments
|
| Janssen Pharmaceuticals | Xarelto | $56 | 2 payments
|
| Pfizer | Eliquis | $42 | 2 payments
|
| Esperion Therapeutics | Nexletol | $27 | 1 payment
|
2023: $2,535
| Merck Sharp & Dohme | Verquvo | $369 | 11 payments
|
| E.R. Squibb & Sons L.L.C. | Camzyos | $315 | 13 payments
|
| Boston Scientific | Watchman Flx | $292 | 7 payments
|
| Janssen Pharmaceuticals | Xarelto | $284 | 11 payments
|
| Novartis Pharmaceuticals | Entresto | $194 | 9 payments
|
| Bayer Healthcare Pharmaceuticals | Adempas | $182 | 4 payments
|
| ShockWave Medical | Shockwave Ivl System With the Shockwave C2 Coronary Ivl Catheter | $162 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Farxiga | $125 | 6 payments
|
| Inspire Medical Systems | Inspire | $99 | 1 payment
|
| Edwards Lifesciences | Edwards Sapien 3 Transcatheter Heart Valve (Thv) | $79 | 3 payments
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $78 | 3 payments
|
| Novo Nordisk | Ozempic | $68 | 4 payments
|
| Amgen | Repatha | $54 | 3 payments
|
| Kiniksa Pharmaceuticals | Arcalyst | $52 | 2 payments
|
| Lexicon Pharmaceuticals | Inpefa | $47 | 2 payments
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $46 | 2 payments
|
| Esperion Therapeutics | Nexletol | $26 | 1 payment
|
| Abbott Laboratories | Mitraclip | $23 | 1 payment
|
| HeartFlow | Ffrct | $22 | 1 payment
|
| Pfizer | Eliquis | $18 | 1 payment
|
2022: $6,854
| Boston Scientific | Watchman Access System | $4,702 | 13 payments
|
| Merck Sharp & Dohme | Verquvo | $349 | 13 payments
|
| E.R. Squibb & Sons L.L.C. | Eliquis | $255 | 10 payments
|
| Abbott Laboratories | Cardiomems | $251 | 3 payments
|
| Biotronik | Biomonitor | $200 | 2 payments
|
| Inspire Medical Systems | Inspire Upper Airway Stimulation System | $177 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Farxiga | $168 | 8 payments
|
| Edwards Lifesciences | Edwards Sapien 3 Transcatheter Heart Valve (Thv) | $165 | 3 payments
|
| Medtronic | Linq II | $115 | 1 payment
|
| Esperion Therapeutics | Nexletol | $95 | 4 payments
|
| Janssen Pharmaceuticals | Xarelto | $80 | 3 payments
|
| Bayer HealthCare Pharmaceuticals | Verquvo | $79 | 3 payments
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $75 | 3 payments
|
| Amarin Pharma | Vascepa | $46 | 2 payments
|
| Amgen | Repatha | $32 | 1 payment
|
| Novartis Pharmaceuticals | Entresto | $25 | 1 payment
|
| Pfizer | Eliquis | $24 | 1 payment
|
| Novo Nordisk | Rybelsus | $17 | 1 payment
|
2021: $1,643
| Boston Scientific | Watchman | $862 | 17 payments
|
| Novo Nordisk | Ozempic | $279 | 6 payments
|
| Silk Road Medical | Enroute .014 Guidewire | $127 | 1 payment
|
| Edwards Lifesciences | Edwards Sapien 3 Ultra Transcatheter Heart Valve | $96 | 3 payments
|
| Amarin Pharma | Vascepa | $90 | 4 payments
|
| Novartis Pharmaceuticals | Entresto | $41 | 2 payments
|
| Amgen | Repatha | $33 | 1 payment
|
| Medtronic | Reveal Linq | $28 | 1 payment
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $25 | 1 payment
|
| Pfizer | Eliquis | $25 | 1 payment
|
| E.R. Squibb & Sons L.L.C. | Eliquis | $22 | 1 payment
|
| Sanofi-Aventis U.S. | Multaq | $16 | 1 payment
|
2020: $4,326
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $3,113 | 22 payments
|
| Lilly USA | Jardiance | $563 | 1 payment
|
| Boston Scientific | Watchman | $232 | 10 payments
|
| Amarin Pharma | Vascepa | $178 | 8 payments
|
| Novo Nordisk | Rybelsus | $139 | 5 payments
|
| Biotronik | None | $46 | 1 payment
|
| Esperion Therapeutics | Nexletol | $24 | 1 payment
|
| E.R. Squibb & Sons L.L.C. | Eliquis | $18 | 1 payment
|
| Medtronic Vascular | Reveal Linq | $14 | 1 payment
|
2019: $13,140
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $6,894 | 45 payments
|
| Biotronik | None | $2,027 | 6 payments
|
| Medtronic Vascular | Reveal Linq | $1,269 | 7 payments
|
| Lilly USA | Jardiance | $1,125 | 2 payments
|
| Amarin Pharma | Vascepa | $920 | 46 payments
|
| AstraZeneca Pharmaceuticals LP | Farxiga | $144 | 2 payments
|
| Novartis Pharmaceuticals | Entresto | $134 | 2 payments
|
| E.R. Squibb & Sons L.L.C. | Eliquis | $126 | 2 payments
|
| Gilead Sciences | Vemlidy | $125 | 1 payment
|
| Boston Scientific | General Pain Management | $124 | 1 payment
|
| Janssen Pharmaceuticals | Xarelto | $75 | 3 payments
|
| Akcea Therapeutics | Tegsedi | $50 | 1 payment
|
| Pfizer | Eliquis | $45 | 2 payments
|
| Regeneron Healthcare Solutions | Praluent | $41 | 2 payments
|
| Abbott Laboratories | Cardiomems Hf System | $22 | 1 payment
|
| Merck Sharp & Dohme | Januvia | $18 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 75.0 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1932291648
- Licence
- CA 0G63910
- Trained
- University of California, Irvine, California College of Medicine, 1987
- Gender
- Male
More record details
- Sole proprietor
- No
- Medicaid ID
- CA 00G639100
- Taxonomy
- Cardiology (207RC0000X)
- Mailing address
- 200 Jose Figueres Ave, #330, San Jose, CA, 95116
- NPI first listed
- 2006-09-29
- NPI last updated
- 2009-04-10
This is when the NPI record was last certified, not a medical board exam.